Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Window of Opportunity Study With Neoadjuvant Pembrolizumab in Colorectal Cancer

NCT03984578 is registered in ClinicalTrials.gov with National Cancer Centre, Singapore as lead sponsor.

NCT NCT03984578
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03984578 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Window of Opportunity Study With Neoadjuvant Pembrolizumab in Colorectal Cancer
Lead sponsor
National Cancer Centre, Singapore
Phase
Phase 2
Overall status
Completed
Start date
June 12, 2019
Completion date
February 28, 2025
Enrollment
33 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer